Federal Appellate Court Revives Tylenol Autism Claims

July 15, 2026

In its Opinion dated July 13, 2026, the United States Court of Appeals for the Second Circuit overturned dismissals of Plaintiffs’ failure-to-warn claims under state law relating to acetaminophen, the active ingredient in Tylenol and its generic equivalents. The Plaintiffs are children, parent[...]

Continue Reading